Wall Street is positive on AbbVie Inc (ABBV). On average, analysts give AbbVie Inc a Strong Buy rating. The average price target is $179.294, which means analysts expect the stock to decline by -1.12% over the next twelve months. That average ranking earns AbbVie Inc an Analyst Rating of 44, which is better than 44% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating ABBV a Strong Buy today. Find out what this means to you and get the rest of the rankings on ABBV!